TSH Blood Test Explained: What It Measures and Why It's Ordered

The TSH blood test is one of the most frequently ordered endocrine laboratory tests. This page explains what the analyte is, what the measurement actually captures, the clinical situations in which the published literature describes it being used, and the assay and interpretation caveats that researchers have documented. This page is for educational purposes only and is not medical advice; consult a licensed physician about any laboratory result, symptom or treatment decision. No part of this page interprets an individual reader's value, and no reference range here should be treated as a personal benchmark — that judgement belongs to the ordering clinician, who sees the assay method, the clinical context and the rest of the panel.

What TSH Is and Where It Comes From

Thyroid-stimulating hormone, also called thyrotropin, is a glycoprotein hormone secreted by thyrotroph cells of the anterior pituitary gland. Its release is stimulated by hypothalamic thyrotropin-releasing hormone and restrained by circulating thyroid hormones. When TSH reaches the thyroid, it binds the TSH receptor on follicular cells and drives iodine uptake, thyroglobulin iodination and the synthesis and release of thyroxine (T4) and triiodothyronine (T3).

The system is a closed negative-feedback loop. When free thyroid hormone concentrations fall, pituitary TSH output rises; when they rise, TSH output falls and can become suppressed. Because the pituitary responds steeply to small changes in thyroid hormone, TSH tends to move earlier and further than T4 does, which is why reviews of thyroid dysfunction have defined the clinical categories by TSH first and peripheral hormones second — for example, subclinical hypothyroidism has been described as an elevated serum TSH accompanied by free T4 within the laboratory's stated interval (PMID 32744440), and subclinical hyperthyroidism as a low or undetectable TSH with free T4 and free T3 within range (PMID 36473171).

What a TSH Blood Test Measures

Sample type and assay format

A TSH test is performed on a venous blood sample, with the measurement made in serum or plasma. Modern laboratories use immunometric ("sandwich") assays on automated analysers: two antibodies bind separate epitopes on the TSH molecule, and the signal generated — chemiluminescent, electrochemiluminescent or fluorescent, depending on the platform — is proportional to the amount of TSH captured. Successive generations of these assays were distinguished by their functional sensitivity, meaning the lowest concentration that can be measured with acceptable reproducibility; this matters most when the question is whether TSH is merely low or fully suppressed, a distinction that reviews of subclinical hyperthyroidism treat as clinically meaningful (PMID 31427038).

Importantly, the assay reports a concentration of immunoreactive TSH. It does not directly measure thyroid hormone, thyroid gland size, autoimmunity or symptoms. Those require separate tests — free T4, free T3, thyroid autoantibodies, imaging — which clinicians may order alongside or reflexively after a TSH result.

What is usually measured with it

• Free T4, used to separate "subclinical" patterns (abnormal TSH, normal free T4) from overt dysfunction, a distinction that structures essentially the whole subclinical thyroid dysfunction literature (PMID 35732440).
• Free T3, which reviews of hyperthyroidism describe as relevant when TSH is suppressed but free T4 is unremarkable (PMID 31427038).
• TSH-receptor antibodies (TRAb), discussed in an update on Graves' disease as central to establishing the autoimmune cause of a suppressed TSH (PMID 30703831).
• Thyroglobulin, which a review of differentiated thyroid cancer described as a tumour marker whose measurement is influenced by TSH stimulation and by anti-thyroglobulin antibody interference (PMID 25444737).

Why Clinicians Order a TSH Test

Across the published reviews, TSH appears in several distinct roles: as a first-line screen when thyroid dysfunction is suspected, as the defining measurement for subclinical disease categories, as a monitoring variable during thyroid hormone replacement or antithyroid therapy, and as a context variable for other thyroid tests. The table below summarises the uses described in the cited literature.

What the Literature Associates With High TSH Levels

Subclinical hypothyroidism

The most commonly discussed cause of a raised TSH with a normal free T4 is subclinical hypothyroidism. A review of the condition described it as a biochemical diagnosis defined by TSH above the reference interval with normal free T4, and reviewed its prevalence, natural history including spontaneous normalisation in a proportion of cases, and the debated associations with cardiovascular outcomes (PMID 32744440). A later narrative review of outcomes and management guidelines reported that recommendations differ between societies and that age, symptom burden, antibody status and the degree of TSH elevation are the variables guidelines use to frame management discussions (PMID 36632720).

The 2013 European Thyroid Association guideline stratified subclinical hypothyroidism into two bands by the extent of TSH elevation — mildly increased TSH of roughly 4.0–10.0 mU/L versus more markedly increased TSH above 10 mU/L — and discussed levothyroxine in relation to those bands and to patient age (PMID 24783053). Those figures are reproduced here as published guideline definitions, not as a reference range for any individual; assay-specific intervals and clinical interpretation are matters for the ordering clinician.

Overt hypothyroidism and other contributors

When TSH elevation is accompanied by a low free T4, the literature describes overt hypothyroidism, and a German review of when and how hypothyroidism is treated discussed levothyroxine replacement and the monitoring of TSH during therapy (PMID 29872890). Reviews of subclinical thyroid dysfunction also noted that a single abnormal TSH does not establish a persistent state and that repeat testing is part of how the condition is characterised (PMID 35732440).

What the Literature Associates With Low TSH Levels

A low or suppressed TSH is the biochemical signature of excess thyroid hormone action on the pituitary. A paediatric review described subclinical hyperthyroidism as low TSH with normal free hormones, discussed its causes in children, and reported that the course is frequently benign in that age group (PMID 36473171). In adults, a review covering Graves' disease, multinodular goitre and subclinical hyperthyroidism described how the underlying cause shapes evaluation and how the degree of TSH suppression figures in management discussions (PMID 31427038).

For autoimmune hyperthyroidism specifically, an update on Graves' disease described TSH-receptor antibody testing, antithyroid drug therapy and the definitive treatment options as the structure of contemporary care (PMID 30703831). Reviews of subclinical thyroid dysfunction more broadly reported associations between persistently low TSH and outcomes such as atrial fibrillation and bone loss, with the strength of association varying by age and by how far TSH is suppressed (PMID 35732440).

TSH in Pregnancy: What Studies Report

Pregnancy changes thyroid physiology, and the literature treats pregnancy TSH separately from non-pregnant adult TSH. A review of hypothyroidism in pregnancy described the association between overt maternal hypothyroidism and adverse obstetric and developmental outcomes, and discussed the continuing debate over subclinical hypothyroidism and universal versus case-finding screening (PMID 24622371). A separate article focused on the cutoff question itself, reporting that fixed trimester-specific thresholds have been challenged and that population- and method-specific reference intervals have been proposed instead (PMID 31598039). The practical implication described in that literature is that the same numerical TSH may be read differently depending on gestational age, assay and local reference data.

TSH in Thyroid Cancer Follow-Up

In differentiated thyroid cancer surveillance, TSH functions less as a diagnosis and more as a condition under which another analyte is interpreted. A review of thyroglobulin in differentiated thyroid cancer described thyroglobulin as the principal biochemical marker of residual or recurrent disease, discussed TSH-stimulated versus unstimulated measurement, and reported that anti-thyroglobulin antibodies interfere with assay results and must be measured alongside (PMID 25444737).

Assay and Interpretation Caveats: What Studies Report

Macro-TSH

Not every elevated TSH reflects an under-active thyroid. A review of macro-TSH described large circulating complexes of TSH — typically TSH bound to immunoglobulin — that are detected by immunoassays but have reduced biological activity, producing a persistently high measured TSH without the expected clinical or free-T4 findings; the authors reported polyethylene glycol precipitation and related laboratory steps as the approach used to identify it, and framed the phenomenon as a diagnostic challenge that can lead to unnecessary treatment if unrecognised (PMID 33777825).

Reference intervals are population- and method-specific

Reference intervals for TSH are derived from reference populations and differ between assay platforms, which is one reason the pregnancy cutoff literature argued for locally derived intervals rather than a single universal number (PMID 31598039). Reviews of subclinical thyroid dysfunction similarly reported that age influences where the distribution of TSH sits, which affects how a borderline value is classified in older adults (PMID 35732440).

A single value is a snapshot

Because TSH secretion is pulsatile and shows diurnal variation, and because transient illness and recent medication exposure can shift it, the subclinical hypothyroidism literature described confirmation on a repeat sample before a persistent category is assigned (PMID 32744440). The narrative review of outcomes and management guidelines reported that guideline disagreement persists precisely because mild biochemical abnormalities frequently resolve or fluctuate (PMID 36632720).

Who Interprets the Result

Nothing on this page constitutes an interpretation of any individual's laboratory value. The literature summarised above describes categories, associations and controversies at the population level; applying any of it to a specific person requires the clinician who ordered the test, who can account for the assay used, the laboratory's own reference interval, concurrent medications, pregnancy status, age and clinical findings. Readers with questions about a TSH result, thyroid symptoms, or any thyroid-related medication should raise them with a licensed physician.

References

• Subclinical hypothyroidism (Minerva Endocrinology, 2021)
• Subclinical hypothyroidism, outcomes and management guidelines: a narrative review and update of recent literature (Current Medical Research and Opinion, 2023)
• Hypothyroidism in pregnancy (The Lancet Diabetes & Endocrinology, 2013)
• 2013 ETA Guideline: Management of Subclinical Hypothyroidism (European Thyroid Journal, 2013)
• Subclinical hyperthyroidism in children (Journal of Pediatric Endocrinology & Metabolism, 2023)
• Update on subclinical thyroid dysfunction (Endocrine Journal, 2022)
• Hypothyroidism — when and how to treat? (Der Internist, 2018)
• Thyroglobulin in differentiated thyroid cancer (Clinica Chimica Acta, 2015)
• Macro-TSH: A Diagnostic Challenge (European Thyroid Journal, 2021)
• Thyroid-Stimulating Hormone Values in Pregnancy: Cutoff Controversy Continues? (Journal of Obstetrics and Gynaecology of India, 2019)
• Update Graves' disease 2019 (Deutsche Medizinische Wochenschrift, 2019)
• Graves' disease, multinodular goiter and subclinical hyperthyroidism (Annales d'Endocrinologie, 2019)